Valuation Metrics Signal Improved Price Attractiveness
Recent data reveals that C J Gelatine’s price-to-earnings (P/E) ratio stands at a striking 130.68, a figure that on the surface appears elevated but is accompanied by a very low PEG ratio of 0.00, indicating negligible earnings growth expectations. The price-to-book value (P/BV) ratio is 1.88, which is modestly below the typical threshold for overvaluation in the specialty chemicals space. These metrics collectively have led to the company’s valuation grade being upgraded from attractive to very attractive by MarketsMOJO’s proprietary scoring system.
Comparatively, peers such as Titan Biotech and Sanstar remain classified as very expensive, with P/E ratios of 68.8 and 94.16 respectively, and EV/EBITDA multiples far exceeding C J Gelatine’s 15.48. This relative valuation advantage suggests that despite the high P/E, the stock may offer better price entry points than many competitors in the sector.
Operational Performance and Profitability Concerns
However, the company’s return on capital employed (ROCE) and return on equity (ROE) remain subdued at 4.14% and 1.44% respectively, signalling limited profitability and efficiency in capital utilisation. These figures are considerably lower than industry averages, which typically range above 10% for well-performing specialty chemical firms. The absence of dividend yield further underscores the company’s constrained cash flow position.
Enterprise value to capital employed (EV/CE) at 1.15 and EV to sales at 0.68 indicate a relatively low valuation on sales and capital employed basis, which may appeal to value investors seeking turnaround opportunities. Yet, the elevated EV to EBIT multiple of 22.85 suggests that earnings before interest and tax remain under pressure, possibly due to operational inefficiencies or market headwinds.
Share Price and Market Capitalisation Dynamics
The stock closed at ₹16.29, down 4.68% on the day, with a 52-week trading range between ₹13.91 and ₹19.85. This recent price decline has contributed to the micro-cap’s market cap grade remaining in the micro-cap category, limiting institutional interest and liquidity. The stock’s performance relative to the Sensex has been mixed; it outperformed the benchmark over the past week and month with returns of 0.49% and 1.75% respectively, while the Sensex declined by 2.70% and 3.68% over the same periods.
However, longer-term returns paint a less favourable picture. Over one year, the stock has declined by 0.67%, underperforming the Sensex’s 8.84% drop, and over three and five years, it has fallen 29.05% and 12.89% respectively, while the Sensex gained 20.68% and 54.39%. Even over a decade, the stock’s 120.14% gain trails the Sensex’s 195.17% appreciation, highlighting persistent challenges in delivering sustained shareholder value.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Mojo Score and Grade Downgrade Reflect Caution
Despite the improved valuation attractiveness, C J Gelatine’s overall Mojo Score stands at 47.0, categorised as a Sell grade, a downgrade from its previous Hold rating as of 22 April 2026. This downgrade reflects concerns over the company’s financial health, growth prospects, and operational metrics. The micro-cap status further compounds risk, as smaller companies often face greater volatility and limited analyst coverage.
Investors should note that while valuation multiples suggest the stock is trading at a discount relative to peers, the underlying fundamentals remain weak. The lack of earnings growth, low returns on capital, and absence of dividend payouts indicate that the company is yet to demonstrate a sustainable turnaround or robust profitability.
Peer Comparison Highlights Valuation Disparities
Within the Specialty Chemicals sector, C J Gelatine’s valuation stands out as very attractive when compared to peers. For instance, Gulshan Polyols and TGV Sraac are also rated very attractive but trade at significantly lower P/E ratios of 28.08 and 9.36 respectively, with EV/EBITDA multiples of 12.18 and 4.24. This suggests that while C J Gelatine’s valuation is appealing on a relative basis, it remains expensive on an absolute P/E basis.
Other competitors such as Stallion India and Amines & Plastics are classified as expensive, with P/E ratios of 37.39 and 31.13 respectively, reinforcing the notion that the sector overall is trading at elevated multiples. The presence of loss-making companies like I G Petrochems, which is rated fair despite negative earnings, further complicates valuation comparisons.
C J Gelatine Products Ltd or something better? Our SwitchER feature analyzes this micro-cap Specialty Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investment Implications and Outlook
For investors, the shift in valuation grade to very attractive presents a potential entry point, especially given the stock’s relative discount to peers and subdued market capitalisation. However, the company’s weak profitability metrics and recent downgrade to a Sell rating warrant caution. The stock’s high P/E ratio, despite a low PEG, suggests that the market is pricing in either a turnaround or significant growth that has yet to materialise.
Long-term investors should weigh the risks associated with micro-cap stocks, including liquidity constraints and volatility, against the possibility of valuation-driven gains if operational improvements occur. Monitoring quarterly earnings, ROCE and ROE trends, and sector dynamics will be critical to reassessing the stock’s attractiveness over time.
In summary, while C J Gelatine Products Ltd’s valuation parameters have improved markedly, the fundamental challenges and market sentiment reflected in its Mojo Score and recent price performance suggest a cautious approach. Investors seeking exposure to the Specialty Chemicals sector may find better risk-adjusted opportunities among peers with stronger financial profiles and more consistent earnings growth.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
